My early research experience includes working for the Editor of Methods In Enzymology, the late Nathan Kaplan, for the winner of the Nobel Prize for the discovery of the Peptide neurotransmitters, Roger Guillemin, for the company that developed what was the world’s largest-selling anti-tumor agent, doxorubicin, Farmitalia Carlo Erba, and collaborated in my Ph.D. work with the discoverer of the most protein toxins in the world, Fiorenzo Stirpe. With the knowledge gained, I have made fundamental discoveries in the Neurosciences, with collaborators too numerous to list, in pain, epilepsy, Alzheimer’s Disease and others through the pioneering of targeting, and eliminating particular neuronal populations. Over 27 years ago, I founded a biotech company, Advanced Targeting Systems, that still exists. My work has gone into clinical trial twice (one is ongoing). My personal expertise is in protein biochemistry, molecular biology, cell biology, and application of new technologies. My publications are widely cited. The academic scientist might think that I am just a toolmaker, providing research tools to scientists that are the creative ones. I would agree to that completely. My best times are when clever biologists approach me and say, “I have an idea.” We discuss the pros and cons and then determine if it might or might not work, and other exigencies. Advanced Targeting Systems allows scientists to buy molecules that can satisfy their research needs.